Hepatocellular carcinoma (HCC) is a common malignancy, and the hepatitis B virus (HBV) is
its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection …

With 296 million cases estimated worldwide, chronic hepatitis B virus (HBV) infection is the
most common risk factor for hepatocellular carcinoma (HCC). HBV-encoded oncogene X …

The hepatitis B virus (HBV) counts as a major global health problem, as it presents a
significant causative factor for liver-related morbidity and mortality. The development of …

Worldwide, an estimated 296 million people are living with chronic hepatitis B virus (HBV)
infection, with a significant risk of morbidity and mortality. Current therapy with pegylated …

Hepatitis B virus (HBV) is a human pathogen that has infected an estimated two billion
people worldwide. Despite the availability of highly efficacious vaccines, universal screening …

Hepatitis B virus (HBV) is a widely prevalent liver infection that can cause acute or chronic
hepatitis. Although current treatment modalities are highly effective in the suppression of …

Hepatitis B virus (HBV) causes chronic infections that are associated with immune
dysfunction. Though T cell impairment is perhaps the most prominent immune change …

Background and aims Hepatitis B virus (HBV)-associated liver cirrhosis (LC), a common
condition with high incidence and mortality rates, is often associated with diabetes mellitus …

Viruses completely rely on the energy and metabolic systems of host cells for life activities.
Viral infections usually lead to cytopathic effects and host diseases. To date, there are still no …

Chronic liver conditions are associated with high mortality rates and have a large adverse
effect on human well-being as well as a significant financial burden. Currently, the only …